Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
about
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancerNeuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasisIncreased μ-opioid receptor expression in metastatic lung cancerMorphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection.Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerEnhancing therapeutic efficacy through designed aggregation of nanoparticles.The evolution and practice of acute pain medicineComparison of oxycodone and morphine on the proliferation, apoptosis and expression of related molecules in the A549 human lung adenocarcinoma cell line.Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery?Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.MOR1 expression in gastric cancer: a biomarker associated with poor outcome.Patient optimization for gastrointestinal cancer surgery.Methylnaltrexone for the treatment of opioid-induced constipation.Regional anaesthesia and cancer metastases: the implication of local anaesthetics.Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasisTreatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility.Prognostic significance of opioid use in the active treatment of advanced colorectal cancer.The mu opioid receptor: A new target for cancer therapy?Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis?Influence of opioids on immune function in patients with cancer pain: from bench to bedside.Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.Intraoperative Fentanyl Consumption Does Not Impact Cancer Recurrence or Overall Survival after Curative Colorectal Cancer Resection.Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?Perioperative events influence cancer recurrence risk after surgery.Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence.Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissuePerioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain Management
P2860
Q28541351-18B3A3D4-7247-41C6-9557-B798871F2A19Q33595867-720BC5F4-9BBB-468E-81C0-B64E69855EFBQ33739171-A40C21FD-1570-4F08-9CD4-4306AEB5985BQ33951500-30DD5DBA-FB80-494B-89A9-96D406EAE52EQ33951506-4ABEFA3A-370F-40DB-ACD4-447113EBB4CBQ35000444-8E668B7B-63DD-43AB-8C67-CFAF163EA30CQ35011905-0D60D4B3-E717-4811-9DAF-2030508B65B1Q35869764-F85762F4-14A1-4CC1-8C01-B836848BC984Q35985440-30863B0F-96AD-49B8-8CAB-7F7B732BB751Q36358281-DA2661F6-11DC-4785-8608-1BF9593D8A12Q36539723-0B834823-8046-46F0-A5E9-80A78DF5F0F2Q37108279-C0129B16-0023-443E-95C4-8430C9A5E1CDQ37676603-4BC89732-CB84-48F4-A308-F66CD5AD7CF9Q37688491-C9AD1CC0-0356-497D-9792-C6E923694341Q37700635-5866305F-461C-48DF-BA2F-F2C1FADA4686Q38061009-DFEAAEFF-612C-406C-AF7E-C480A5EFEE2FQ38069607-D0C52D22-33DA-4836-ADBE-39FCE560A85BQ38153450-8D1F0C93-2E02-4A15-A0B4-0F9CD7DDEF87Q38182143-DEB685F3-DB5B-43C3-884A-32394845CB3BQ38202638-0BBB3730-A044-441B-B187-0D0A9AC698BEQ38292435-E5284EF9-4A98-4A12-8AD2-A94BA53B5264Q38515846-A32FA61E-BAC0-4F5E-A3AE-ACD2946A7424Q38615477-0A0FE088-1817-48B7-972B-690783744F85Q38736927-634372F7-2A15-4F72-B2B0-088FA0113AA9Q39034167-939E38A0-758B-4CD8-90FD-76C66D66EF09Q39442254-46C7F83A-0A20-4B45-B154-AB29DAE8C35DQ40052118-B83E0D20-18AB-4687-9DE9-B94561B301D4Q41644051-5ACB36C3-6F78-44AA-AAE4-40F417800A93Q47217213-8E984D86-B0FE-47E4-A524-18778E64358DQ47273706-32C3107D-8504-4005-806B-F4749CDBFF60Q49288734-6CB70787-14B5-4943-8783-CC9D3B1ABC79Q57135037-CC90A4E0-5ED0-450A-B151-0F057C0F48F2Q57493011-C672F513-7562-4695-9AC3-056C8534E4F4
P2860
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@en
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@nl
type
label
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@en
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@nl
prefLabel
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@en
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@nl
P2093
P1433
P1476
Overexpression of the μ-opioid ...... tumor growth, and metastasis.
@en
P2093
Bolot Mambetsariev
Frances E Lennon
Jonathan Moss
Patrick A Singleton
Tamara Mirzapoiazova
P304
P356
10.1097/ALN.0B013E31824BABE2
P407
P50
P577
2012-04-01T00:00:00Z